Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2551-2025

Preventive Maintenance (PM) Kit ICEFX, Material Number (UPN) SPRPM8000 Recall

Preventive Maintenance (PM) Kit ICEFX, Material Number (UPN) SPRPM8000

FDA recall Class II

Ongoing

FDA lists this Class II recall for Preventive Maintenance (PM) Kit ICEFX, Material Number (UPN) SPRPM8000. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2551-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 18, 2025
FDA report date
Sep 17, 2025
Quantity in commerce
1 unit
Distribution
See key details
FDA cause
Process control

What is being recalled?

Preventive Maintenance (PM) Kit ICEFX, Material Number (UPN) SPRPM8000

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

Batch: 108159110

View the original FDA recall notice

Why was this product recalled?

Certain desiccant tube subassemblies were built with end caps that were not correctly tightened.

What actions did BOSTON SCIENTIFIC CORPORATION take?

An Urgent Medical Device Correction dated 8/18/25 was sent to customers. Customers should cease use of the systems listed in Table 1 and segregate them until a Boston Scientific representative has corrected this issue. A Boston Scientific Field Service Engineer will contact your facility to schedule the correction of your system. For patients in whom an impacted device has already been used, there are no specific recommendations beyond the local standard post-procedure care. If you require additional assistance or more information regarding this communication, please contact your local Boston Scientific representative. The Acknowledgement Form enclosed with this product correction must be completed and returned even if you do not have any affected units. An Urgent Medical Device Removal notification letter dated 8/18/25 was sent to a customer regarding the PM Kit ICEFX. Instructions: 1. Further distribution or use of any devices (Table 1) affected by this removal should cease immediately. Do NOT use affected devices and remove those devices from your facility s inventory. Segregate the units in a secure place until they can be returned to Boston Scientific. 2. Immediately post this information in a visible location near the affected devices to ensure it is readily accessible to all handlers and users of the device. 3. Forward this notice to any healthcare professional from your organization and to any facilities where affected devices have been transferred, including hospitals or sites within your network. 4. Complete and return the enclosed Reply Verification Tracking Form per the enclosed instructions on page three. 5. Return affected devices. If you require additional assistance or more information regarding this communication, please contact your local Boston Scientific representative.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology